Weekly updateCompaniesRecruiting servicePost a job
Day One Biopharmaceuticals

Day One Biopharmaceuticals

    Company info:

  • 51-100
  • 2018
  • San Francisco, CA
  • 100-500M


dayonebio.com

linkedin.com


Claim company profile

About company:

Day One Biopharmaceuticals is developing therapies for patients of all ages with life-threatening diseases. The most common childhood brain cancer is pediatric low-grade glioma (pLGG), and it currently lacks effective cures. Through partnering with leading clinical oncologists, families and scientists, Day One is identifying, acquiring and developing cancer treatments. Day One’s lead product, DAY101 (tovorafenib), is in Phase 1/2 clinical trials for treatment against pLGG. DAY101 is an orally-taken, brain-penetrant pan-RAF inhibitor. Day One’s pipeline also includes pimasertib, a small molecule inhibitor of MEK-1/-2.

Jobs:

Day One Biopharmaceuticals
Clinical Drug Supply Manager (Contract)
San Francisco, CA|21 days ago
Day One Biopharmaceuticals
Clinical Trial Specialist (Contract)
San Francisco, CA|21 days ago
Day One Biopharmaceuticals
Director, Translational Research
San Francisco, CA|29 days ago
Day One Biopharmaceuticals
Vice President Information Technology
San Francisco, CA|47 days ago
Day One Biopharmaceuticals
Senior Vice President, External Discovery and Research
San Francisco, CA|100+ days ago
Day One Biopharmaceuticals
Chief Commercial Officer
San Francisco, CA|100+ days ago
Day One Biopharmaceuticals
Future Opportunities
Open|100+ days ago


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com